Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
NCT07656727Phase 2Active, not recruiting
- Sponsor
- BioAge Labs
- Start
- Jun 2026
- Primary completion
- Nov 2026
- Countries
- 2
01
Overview
A Phase 2 trial of BGE-102 in obesity, sponsored by BioAge Labs. Started Jun 2026; status: active, not recruiting.
02
Drugs
BGE-102
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07656727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07656727.